Breaking News Instant updates and real-time market news.

SPHS

Sophiris Bio

$2.57

-0.06 (-2.28%)

09:16
08/29/18
08/29
09:16
08/29/18
09:16

Piper expects shares of Sophiris Bio to open 'sharply higher'

Piper Jaffray analyst Christopher Raymond expects shares of Sophiris Bio to open "sharply higher" on this morning's formal confirmation that topsalysin was not a factor in a patient death seen in the drug's Phase 2b study in patients with localized prostate cancer. In that the death "cast a pall over an otherwise positive data release, we expect the stock to react favorably this morning," Raymond tells investors in a research note. He points out that moving forward, Sophiris has indicated a Phase 3 study confirming the clinical response rate is planned likely next year. The analyst likes the set-up for topsalysin and keeps an Overweight rating on Sophiris Bio with a $7 price target. The stock in premarket trading is up 23%, or 58c, to $3.14.

SPHS Sophiris Bio
$2.57

-0.06 (-2.28%)

06/25/18
MAXM
06/25/18
NO CHANGE
MAXM
Sophiris Bio's topsalysin remains a vaible PC drug candidate, says Maxim
Maxim analyst Jason McCarthy said Buy rated Sophiris Bio shares are being pressured by a patient death, which the cause remains unknown. The analyst said the data for single administration is positive and there have bee no safety issues. McCarthy continues to believe that topsalysin remains a viable PC drug candidate, but notes we have to wait on repeat administration data later in 2018 and a report on the patient.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $7
PIPR
Overweight
Piper says Sophiris Bio 'worth sticking with' despite patient death in trial
A patient death after retreatment has "placed a cloud" over Sophiris Bio's topsalysin program despite efficacy data that was "clearly a home run," according to Piper Jaffray analyst Christopher Raymond. He sees a good chance the incident may end up not being categorized as drug-related, noting that topsalysin previously had shown a "pristine safety profile," and Raymond thinks the stock is "worth sticking with" at this point. The analyst, who is reserving judgment until more detail on topsalysin's role in the death is available, thinks there remains a credible path forward even if the death is deemed drug related. He keeps an Overweight rating and $7 price target on Sophiris shares, which fell about 40% to $2.24 today.
06/26/18
PIPR
06/26/18
NO CHANGE
Target $7
PIPR
Overweight
Sophiris Bio 'worth sticking with' after patient death, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating and $7 price target on Sophiris Bio following disclosure of Phase 2b topsalysin data in localized prostate cancer. In a research note to investors, Raymond contended that while a patient death is "never a great headline," and that death after retreatment has now placed a cloud over the program, he thinks there is a good chance this incident may end up not being categorized as drug-related, and thinks it's worth "sticking with it here." Raymond sees a "credible" path forward with single administration, and urges investors to be patient on the name as clarity on the death and clinical path come more into focus.
08/14/18
PIPR
08/14/18
NO CHANGE
Target $7
PIPR
Overweight
Sophiris Bio topsalycin trial death disclosure imminent, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $7 price target on Sophiris Bio after its "uneventful" Q2 report. The analyst says that while the company did not update on the cause of death of one of its Phase 2b topsalycin trial patients, conversations with the management suggest that the disclosure is "imminent". Raymond adds that with the cause of death being announced, the "cloud" over the program will be lifted, allowing investors to focus on the drug's "impressive efficacy".

TODAY'S FREE FLY STORIES

KKR

KKR

$28.12

-0.13 (-0.46%)

21:13
09/25/18
09/25
21:13
09/25/18
21:13
Hot Stocks
KKR forms management company to provide health care services in China »

KKR announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$70.38

0.43 (0.61%)

21:11
09/25/18
09/25
21:11
09/25/18
21:11
Hot Stocks
Agilent acquires ACEA Bioscience for $250M in cash »

Agilent Technologie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

EQM

EQT Midstream Partners

$52.64

-2.16 (-3.94%)

20:58
09/25/18
09/25
20:58
09/25/18
20:58
Recommendations
EQT Midstream Partners analyst commentary at MUFG »

EQT Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

20:42
09/25/18
09/25
20:42
09/25/18
20:42
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IGC

IGC, Inc

$2.32

-0.22 (-8.66%)

20:40
09/25/18
09/25
20:40
09/25/18
20:40
Hot Stocks
IGC to enter Hemp/CBD-infused energy drink space »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$57.10

-0.33 (-0.57%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Breaking Periodicals news story on Delta Air Lines »

Delta Air Lines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Trump considering keeping Deputy AG Rosenstein, WSJ says »

Donald Trump has…

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCE

Arco Platform

$0.00

(0.00%)

20:31
09/25/18
09/25
20:31
09/25/18
20:31
Syndicate
Arco Platform 11.111M share IPO priced at $17.50 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KMX

CarMax

$75.87

-0.01 (-0.01%)

20:25
09/25/18
09/25
20:25
09/25/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

AINC

Ashford

$75.95

-11.75 (-13.40%)

20:23
09/25/18
09/25
20:23
09/25/18
20:23
Syndicate
Ashford 270K share Secondary priced at $74.50 »

UBS, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 26

    Sep

ANAB

AnaptysBio

$94.68

-7.25 (-7.11%)

20:21
09/25/18
09/25
20:21
09/25/18
20:21
Syndicate
AnaptysBio 2.2M share Secondary priced at $94.46 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SF

Stifel Financial

$53.96

-0.08 (-0.15%)

20:01
09/25/18
09/25
20:01
09/25/18
20:01
Hot Stocks
Stifel Financial and Everbright Sun Hung Kai establish strategic partnership »

Stifel Financial and Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

I

Intelsat

$27.08

4.365 (19.22%)

19:59
09/25/18
09/25
19:59
09/25/18
19:59
Hot Stocks
Intelsat and Azercosmos announce successful satellite launch »

Intelsat S.A. and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$30.88

0.66 (2.18%)

19:49
09/25/18
09/25
19:49
09/25/18
19:49
Hot Stocks
Breaking Hot Stocks news story on Skyline »

Centerbridge Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

, AIR

AAR Corp.

$46.03

1.04 (2.31%)

19:28
09/25/18
09/25
19:28
09/25/18
19:28
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$25.29

-0.24 (-0.94%)

AIR

AAR Corp.

$46.03

1.04 (2.31%)

VSTM

Verastem

$7.15

-1.74 (-19.57%)

CGIX

Cancer Genetics

$1.22

-0.01 (-0.81%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

NLSN

Nielsen

$27.21

0.055 (0.20%)

CYH

Community Health

$3.41

-0.08 (-2.29%)

AUPH

Aurinia Pharmaceuticals

$5.89

0.02 (0.34%)

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

ABBV

AbbVie

$93.78

0.34 (0.36%)

NKE

Nike

$84.79

0.52 (0.62%)

CTAS

Cintas

$212.99

1.81 (0.86%)

LULU

Lululemon

$158.42

1.04 (0.66%)

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 04

    Oct

  • 05

    Oct

  • 26

    Sep

CBS

CBS

$56.54

-0.07 (-0.12%)

19:19
09/25/18
09/25
19:19
09/25/18
19:19
Hot Stocks
CBS names Richard Parsons interim chairman »

Richard Parsons has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ZUMZ

Zumiez

$27.00

-0.55 (-2.00%)

19:09
09/25/18
09/25
19:09
09/25/18
19:09
Initiation
Zumiez initiated at DA Davidson »

Zumiez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$97.54

0.26 (0.27%)

, TJX

TJX

$110.33

0.605 (0.55%)

19:03
09/25/18
09/25
19:03
09/25/18
19:03
Initiation
Ross Stores, TJX initiated at DA Davidson »

Ross Stores initiated…

ROST

Ross Stores

$97.54

0.26 (0.27%)

TJX

TJX

$110.33

0.605 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MNOV

MediciNova

$11.68

-0.17 (-1.43%)

19:01
09/25/18
09/25
19:01
09/25/18
19:01
Hot Stocks
MediciNova announces 'positive' FDA feedback on Phase 3 plan for MN-166 »

MediciNova announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$140.00

-0.56 (-0.40%)

18:58
09/25/18
09/25
18:58
09/25/18
18:58
Initiation
PVH Corp. initiated at DA Davidson »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

18:50
09/25/18
09/25
18:50
09/25/18
18:50
Initiation
Canada Goose initiated at DA Davidson »

Canada Goose initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.91

-0.55 (-0.68%)

18:47
09/25/18
09/25
18:47
09/25/18
18:47
Periodicals
Philip Morris hits streets to sell older smokers on new devices, Bloomberg says »

Philip Morris is moving a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

URBN

Urban Outfitters

$40.06

-0.32 (-0.79%)

18:45
09/25/18
09/25
18:45
09/25/18
18:45
Initiation
Urban Outfitters initiated at DA Davidson »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

SVMK

SurveyMonkey

$0.00

(0.00%)

18:35
09/25/18
09/25
18:35
09/25/18
18:35
Syndicate
SurveyMonkey 15M share IPO priced at $12.00 »

The shares are expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

LULU

Lululemon

$158.42

1.04 (0.66%)

18:34
09/25/18
09/25
18:34
09/25/18
18:34
Initiation
Lululemon initiated at DA Davidson »

Lululemon initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.